Taking tiny doses of GLP-1 medication has been touted for weight management, perimenopause symptoms, even longevity. But is ...
Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...
Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...
Jacobs Solutions CEO Bob Pragada joins 'Squawk Box' to discuss the building opportunities of life science facilities to meet ...
Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...
Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...
Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for abuse.
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...
6d
Hosted on MSNGLP-1 Drugs and Colonoscopy; GI Symptoms Post-COVID; Identifying High-Risk Barrett'sA systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...
A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.
Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results